top of page

Nagamine T. Prospects for the Health Care System in the 21ST Century –Suggestions on the Importance of Risk Management – JMJA 2003;46 (1): 36-45.

  1. Ngamine T. Hypoglycemia associated with insulin hypersecretion following the addition of olanzapine to conventional antipsychotics. Neuropsychiatr Dis Treat. 2006; 2 (4): 583-5.

  2. Nagamine T. Direct metabolic effects of risperidone and olanzapine in Japanese schizophrenic patients. Neuropsychiatr Dis Treat. 2007; 3(1): 177-9.

  3. Nagamine T. Serum substanceP levels in patients with chronic schizophrenia treated with typical or atypical antipsychotics. Neuropsychiatr Dis Treat. 2008; 4(1):289-94.

  4. Nagamine T. Olanzapine-induced elevation of serum triglyceride levels in a normal weight patient with schizophrenia. Intern Med. 2008; 47(3): 181-2.

  5. Nagamine T. Effects of risperidone and olanzapine on remnant-like lipoprotein particle cholesterol (RLP-C) in schizophrenic patients. Neuropsychiatr Dis Treat. 2008;4(2):481-6 .

  6. Nagamine T, Nakayama H. Serum Substance P Concentration in Pneumonia Patients with Chronic Schizophrenia. Int Med J.2009;16(3):181-2.

  7. Nagamine T: Abnormal laboratory values during the acute and recovery phases in schizophrenic patients: A retrospective study. Neuropsychiatr.Dis.Treat. 2010;6:281-8.

  8. Nakamura M, Nagamine T. Severe hyperglycemia induced by olanzapine was improved with a recovery of insulin secretion after switching to risperidone and introducing insulin therapy. Intern Med. 2010;49:2635-7.

  9. Nagamine T. Choking Risk among Psychiatric Inpatients. Neuropsychiatr. Dis. Treat. 2011;7:381-2.

  10. Nagamine T. Are combination therapies with aripiprazole and other antipsychotics pharmacologically rational? Clin Neuropsychopharmacol Ther.2011;2:32-3.

  11. NagamineT. The frequency of abnormal laboratory values in the treatment of acute-phase schizophrenia. Int Med J. 2011;18:183-4.

  12. Nagamine T. What does antipsychotic-associated hypoprolactinemia mean in patients with chronic schizophrenia? Clin Neuropsychopharmacol Ther.2011;2:43-4.

  13. Nagamine T. Are psychotropic drugs involved in gallstone-induced acute abdomen in inpatients with schizophrenia? Clin Neuropsychopharmacol Ther.2012;3:1-2.

  14. Nagamine T. Antipsychotic-induced hyperthermia in patients with behavioral and psychological symptoms of dementia. Clin Neuropsychopharmacol Ther.2012;3:5-7.

  15. Nagamine T, Sato N, Seo G. Probiotics Reduce Negative Symptoms of Schizophrenia: A Case Report. Int Med J.2012;19(1):72-3.

  16. Ngamine T. Antipsychotic-Induced Hypoprolactinemia; A New Category of Adverse Events? Int Med J.2012;19(3):281-2.

  17. Nakamura M, Nagamine T. Hypoprolactinemia and Extrapyramidal symptoms treated with Aripiprazole in male schizophrenia or psychotic affective disorder subjects. Clin Neuropsychopharmacol Ther.2012;3:18-22.

  18. Nagamine T. Metabolic Effects of Valproic Acid Augmentation in Male Schizophrenic Patients. Clin Neuropsychopharmacol Ther.2012;3:23-5.

  19. Nakamura M, Tahara K, Nagamine T. Discontinuation of Multiple Psychotropic Drugs for Bipolar Disorder May Cause Reversible Encephalopathy. Int Med J. 2012;19(4):342-3.

  20. Nagamine T. Carnitine Deficiency and Severe Hypoglycemia Associated with Valproic Acid. Clin Neuropsychopharmacol Ther. 2012;3:37-9.

  21. Nakamura M, Satoh Y, Hiraoka A, Fujita Y, Nagamine T. Duloxetine-induced Hyponatremia in the Elderly. Clin Neuropsychopharmacol Ther. 2012;3:33-36.

  22. Ozasa R, Okada T, Nadanaka S, Nagamine T, Zyryanova A, Harding H, Ron D and Mori K: The Antipsychotic Olanzapine Induces Apoptosis in Insulin-secreting Pancreatic β Cells by Blocking PERK-mediated Translational Attenuation. Cell Struct Funct. 2013;38:183-195.

  23. Nagamine T. Atypical Antipsychotics May Have Dopamine Agonistic Activity Because of Their Pharmacophore. Int Med J. 2013;20(5):552-4.

  24. Nagamine T: Why do the new drugs based on the glutamate hypothesis seem to be difficult to exert clinical efficacy solely in schizophrenia? Int Med J. 2013;20(5):542-3.

  25. Nakamura M, Nagamine T. Metabolic Effects of Sodium Valproate on Atypical Antipsychotics in Japanese Psychotic Patients. Clin Neuropsychopharmacol Ther. 2013;4:13-9.

  26. Nagamine T. Lithium Intoxication Associated with Angiotensin II Type 1 Receptor Blockers in Women. Clin Neuropsychopharmacol Ther. 2013;4:23-5.

  27. Nagamine T, Sanada Y. Standard Deviation of the CT values in polydipsic schizophrenia. Int Med J.2014;21(3):254.

  28. Nagamine T, Yonezawa H, Nakamura K, Takahashi T, Sanada Y, and Terazono T. Refractory Pneumonia is associated with a Decrease of Visceral Adipose Tissue in Japanese Schizophrenia Patients. Int Med J.2014;21(4):512-3.

  29. Nagamine T. Dose olanzapine impair pancreatic beta-cell function directly? Clin Neuropsychopharmacol Ther. 2014;5:23-5.

  30. Nagamine T. Cerebral edema secondary to psychogenic polydipsia induced by tandospirone as add-on to olanzapine therapy. Clin Neuropsychopharmacol Ther. 2014;5:26-8.

  31. Nakamura M, Masaoka Y, Nagamine T. Olanzapine-induced severe hyperglycemia was completely reversed by the restoration of insulin secretion after switching to aripiprazole and initiating insulin therapy. Clin Neuropsychopharmacol Ther. 2014;5:29-33.

  32. Nagamine T, Sanada Y, Nakamura K, Yonezawa H, Takahashi T, Terazono T.  Pituitary CT Levels in Mineralocorticoid Responsive Hyponatremia of the Elderly.  Int.Med.J. 2014;21(6):570.

  33. Nagamine T, Nakamura M. Antipsychotic-Induced Metabolic Abnormalities May Increase the Risk for Excess Mortality in Psychiatric Patients. Int Med J.2015;22(1):23.

  34. Nakamura M, Nagamine T. Hyperammonemia and Carnitine Deficiency Treated with Sodium Valproate in Psychiatric Setting. Int.Med.J.2015;22(3):132-5.

  35. Nagamine T, Yonezawa H, Nakamura K, Takahashi T, Terazono T. Adam-Stokes Syndrome Caused by Lithium Intoxication. Int Med J.2015;22(4):343-4.

  36. Nagamine T. Asymmetry and Decreased Size in the Hippocampus of Dementia Patients. Int Med J. 2015;22(4):345.

  37. Nagamine T. ‘Ultimatum Game’ in a patient with psychogenic polydipsia. Int Med J. 2015;22(4):346.

  38. Nagamine T, Yonezawa H, Nakamura K, Takahashi T, Terazono T. Hypoglycemic Attack Associated with Valproate. Int Med J.2015;22(5):442-3.

  39. Nagamine T. Bacterial Translocation in Schizophrenia; Gut Microbiota is a New Target for Treating Schizophrenia. Int Med J. 2015;22(5):444-5.

  40. Nakamura M, Nagamine T. The effect of carnitine supplementation on hyperammonemia and carnitine deficiency treated with valproic acid in psychiatric setting. Innov Clin Neurosci.2015;12(9-10):18-24.

  41. Nakamura M, Nakatsu K, Nagamine T. Sinus node dysfunction after acute lithium treatment at therapeutic levels. Innov Clin Neurosci.2015;12(11-12):18-20.

  42. Nagamine T, Yonezawa H, Nakamura M. Aripiprazole, A Dopamine D2 Receptor Partial Agonist, Attenuates Post Electroconvulsive Prolactin Increase. Int Med J. 2016;23(1):100-101.

  43. Nagamine T, Yamaoka N, Yonezawa H, Nakamura K, Takahashi T, Terazono T. Fasting Insulin Levels in Individuals with Non-Diabetic Alzheimer’s Disease. Int Med J. 2016;23(1):2.

  44. Nakamura M, Seki M, Sato Y, Nagamine T. Quetiapine-induced bradycardia and hypotension in the elderly. Innov Clin Neurosci. 2016;13(1-2):34-36.

  45. Nagamine T, Yamaoka N, Nakamura M. Iron Depletion Affects Dopamine Neurotransmissions. Clin Neuropsychopharmacol Ther.2016;7:9-10.

  46. Nagamine T. Family Function Among Caregivers of Dementia People with Neuropsychiatric Symptoms; A Study Using Smilkstein’s Family APGAR Items. Int Med J.2016;23(3):306-307.

  47. Nagamine T. Sudden Cardiac Death Associated with Long Acting Injectable Antipsychotics. Int Med J. 2016;23(3):211-213.

  48. Nagamine T. Decrease in Reciprocal Fairness Feeling of Patients with Polydipsic Schizophrenia. Innov Clin Neurosci.2016;13(5-6):14-15.

  49. Nakamura M, Nagamine T, Sato G, Bessho K. Prolactin Levels After Switching to Paliperidone Palmitate in Patients with Schizophrenia. Innov Clin Neurosci. 2016; 13(5-6):28-30.

  50. Nagamine T, Yamaoka N, Yonezawa H, Nakamura K, Takahashi T, Terazono T. Abdominal Compartment Syndrome Caused by Chronic Constipation in a patient with Alzheimer’s Disease. Int Med J.2016;23(4):450-451.

  51. Nagamine T. Fetal Hypernatremia in Schizophrenia Patients with Polydipsia. Int Med J.2016;23(4):452-453.

  52. Nagamine T. Severe hypoglycemia associated with risperidone. Psychiatry Clin Neurosci. 2016;70(9):421.

  53. Nagamine T. Neuroleptic Malignant Syndrome Induced by Abrupt Withdrawal of Donepezil. Int Med J. 2016;23(5):470-471.

  54. Nagamine T. Antipsychotic-induced severe hypoglycemia. Atlas of Science. 2016 Nov 15.

  55. Nagamine T. Emergency Cardiovascular Care for Psychiatric Patients with Sudden Cardiac Arrest; The CBA2 Method. Int Med J.2016;23(6):605-606.

  56. Nagamine T. Complete Recovery from Cardiac Arrest Caused by Risperidone-Induced Hypothermia. Innov Clin Neurosci.2016;13(11-12):28-31.

  57. Nagamine T. Clonazepam-Induced Gastric Dilatation. Int Med J. 2016;23(6):724.

  58. Nagamine T. Severe hypoglycemia associated with tiapride in an elderly patient with diabetes and psychosis. Innov Clin Neurosci.2017;14(1-2):12-13.

  59. Nakamura M, Nagamine T. Carnitine supplementation treated with valproic acid attenuate antipsychotic-induced hyperprolactinemia in a psychiatric setting. Int Med J.2017;24(2):183-185.

  60. Nakamura M, Nagamine T. Neuroendocrine, autonomic and metabolic responses to an orexin antagonist, Suvorexant in patients with insomnia. Innov Clin Neurosci. 2017;14(3–4):30–37.

  61. Ido Y, Nagamine T, Okamura T, Tasaki M, Fukuo K. Prebiotic Lactosucrose May Improve not only Constipation but also Psychotic Symptoms of Schizophrenia. Int Med J.2017;24(3):305-306.

  62. Nakamura M, Nagamine T. Pituitary GABA Receptor Stimulation by Carnitine may be a New Strategy for Antipsychotic-Induced Hyperprolactinemia. Psychiatry Clin Neurosci. 2017 Aug;71(8):571-572.

  63. Nagamine T, Nakamura M. L-carnitine attenuates antipsychotic-induced hyperprolactinemia by stimulating pituitary GABA receptors. Atlas of Science. 2017.Aug 22.

  64. Nagamine T. The Reverse-Stroop Test Predicts Self-Discipline of the Money of Schizophrenia Patients. Int Med J. 2017;24(5):428-429.

  65. Nakamura M, Fujita Y, Nagamine T. Serum prolactin levels might become a useful marker for switching strategy to paliperidone palmitate in male schizophrenia patient. Asia Pac Psychiatry. 2018 Mar;10(1). doi: 10.1111/appy.12300.

  66. Nakamura M, Nagamine T. Suvorexant as an orexin antagonist may regulate serum glucose levels in psychiatric patients with insomnia. Psychiatry Clin Neurosci. 2017;71:844.

  67. Nagamine T, Nakamura M. Suvorexant, a dual orexin receptor antagonist, may work as a glucose regulatory switch. Atlas of Science. 2017 Oct 24.

  68. Nagamine T. Responsibility of the doctor who prescribes serotonin and noradrenaline reuptake inhibitor (SNRI) for patients with chronic musculoskeletal pain. Psychiatry Clin Neurosci.2018;72:45-46.

  69. Nagamine T. Prolactin Levels in Alzheimer’s Disease Patients Treated with or without Acetylcholinesterase Inhibitors. Int Med J.2017;24(6):488-489.

  70. Nagamine T. Serotonin and noradrenaline reuptake inhibitor (SNRI) for chronic musculoskeletal pain may be a red herring? Atlas of Science. 2017 Nov.29.

  71. Nakamura M, Nagamine T. Adrenaline reversal may be an unwarranted distraction during emergency cardiovascular care for patients treated with antipsychotics. Asia Pac Psychiatry. 2018 Jun;10(2):e12308. doi: 10.1111/appy.12308.

  72. Nakamura M, Nagamine T. Serum prolactin levels are associated with prefrontal hemodynamic responses using near-infrared spectroscopy in male psychotic patients treated with antipsychotics. Psychiatry Clin Neurosci. 2018;72(5):374-375.

  73. Nagamine T, Ido Y, Nakamura M, Okamura T. 4G-β-D-Galactosylsucrose as a prebiotics may improve underweight in inpatients with schizophrenia. Biosci Microbiota Food Health.2018;37(2):45-47.

  74. Nagamine T, Nakamura M. Prolactin regulates neurovascular coupling in male psychotic patients. Atlas of Science.2018 Feb.28.

  75. Nagamine T. Sex Differences in Antipsychotic-Related Constipation. Int Med J.2018;25(2):130.

  76. Nagamine T. Combination therapy with blonanserin and other antipsychotics may alleviate psychotic symptoms in patients with dopamine supersensitivity psychosis. Int Med J. 2018;25(2):131-132.

  77. Kawasaki K, Nagamine T, Watanabe T, Suga T, Trang T.H Tu, Sugawara S, Mikuzuki L, Miura A, Shinohara Y, Yoshikawa T, Takenoshita M, Toyofuku A. An increase in salivary flow with amitriptyline may indicate treatment resistance in burning mouth syndrome. Asia Pac Psychiatry. 2018; Article DOI: 10.1111/appy.12315

  78. Watanabe T, Kawasaki K, Trang T.H Tu, Suga T, Sugawara S, Mikuzuki L, Miura A, Shinohara Y, Yoshikawa T, Takenoshita M, Toyofuku A, Nagamine T. The QTc shortening with amitriptyline may indicate treatment resistance in chronic nonorganic orofacial pain. Clin Neuropsychopharmacol Ther. 2018;9:12-14.

  79. Nagamine T. Olanzapine and Diabetic Ketoacidosis; What is the Underlying Mechanism? Innov Clin Neurosci. 2018;15(3–4):11–12.

  80. Nakamura M, Nagamine T. Prolactin levels in Schizophrenia patients switched from daily to once-monthly Aripiprazole treatment. Innov Clin Neurosci. 2018;15(3–4):13–14.

  81. Watanabe T, Kawasaki K, Trang T.H Tu, Toyofuku A, Nagamine T. Amitriptyline increases salivary flow in treatment-resistant burning mouth syndrome: What is the underlying mechanism? Atlas of Science.2018; April 20.

  82. Nagamine T, Ido Y, Okamura T, Nakamura M. The Effect of 4G-β-D-Galactosylsucrose on Antipsychotic Related Constipation. Int Med J. 2018;25(3):138-140.

  83. Watanabe T, Nagamine T, Mikuzuki L, Aota Y, Suga T, Trang T.H Tu, Takenoshita M, Toyofuku A. An increase in corrected QT interval may indicate a good clinical response to amitriptyline in female patients with burning mouth syndrome. Neurology and Neurobiology. 2018;1(1):1-3.

  84. Nakamura M, Nagamine T. Serum electrolyte levels may be associated with prefrontal hemodynamic responses in near-infrared spectroscopy. J Near Infrared Spectrosc. 2018;26(4):229-234.

  85. Nakamura M, Nagamine T. Metabolic changes in patients with schizophrenia switched from olanzapine to asenapine or clozapine. Innov Clin Neurosci. 2018;15(7-8):11-14.

  86. Ido Y, Nagamine T. The Eeffect of Prebiotic Lactosucrose on Serum IgE Levels in Allergic People: A Pilot Study in Japan. Int Med J. 2018;25(6):389-390.

  87. Suga T, Watanabe T, Aota Y, Nagamine T, Toyofuku A. Burning Mouth Syndrome: the challenge of an aging population. Geriatr Gerontol Int. 2018;18(12):1649-1650.

  88. Watanabe T, Nagamine T, Mikuzuki L, Aota Y, Suga T, Trang T.H Tu, Kawasaki K, Shinohara Y, Takenoshita M, Toyofuku A. Changes in Corrected QT Interval may be associated with Clinical Responses in Burning Mouth Syndrome. Int Med J. 2019;26(1):13-14.

  89. Nagamine T. Matsumoto Y, Nakamura M. Combination probiotics may prevent Clostridium difficile infection among elderly patients undergoing an orthopedic surgery. Biosci Microbiota Food Health. 2019;38(1):31-33.

  90. Takayama A, NagamineT, Matsumoto Y, Nakamura M. Duloxetine and Angiotensin II Receptor Blocker Combination Potentially Induce Severe Hyponatremia in an Elderly Woman. Intern Med. 2019; doi: dx.doi.org/10.2169/internalmedicine.2059-18

  91. Takayama A, Takeshima T, Nakashima Y, Yoshidomi T, Nagamine T, Kotani K. A Comparison of Methods to Count Breathing Frequency. Respir Care. 2019;64(4) Apr 16. pii: respcare.06451.

  92. Nakamura M, Nagamine T. Discrepancy between Neuroimaging-guided Diagnosis Using Near-Infrared Spectroscopy and Clinical Diagnosis in Major Psychiatric Disorders. Int Med J. 2019;26(3):166-168.

  93. Takayama A, Nagamine T. Successful Treatment of Necrotizing Fasciitis following Cat Bites in an Immunocompromised Patient by Ampicillin-sulbactam and Intravenous Immunoglobulin. Int Med J.2019;26(3):191-193.

  94. Takayama A, Nagamine T. Neurogenic Bladder and Urinary Retention Associated with Mequitazine in an Elderly Male Patient. Int Med J.2019;26(3):194-195.

  95. Nagamine T. Is primary prevention of Clostridioides difficile infection possible with combination probiotics in elderly orthopedic patients? Biosci Microbiota Food Health. 2019;38(3):73-74.

  96. Nagamine T. Hyperglycemic Hyperosmolar State Associated with Fournier’s Gangrene. Int Med J.2019;26(4):353-354.

  97. Nagamine T. Iliacus Muscle Abscess Associated with Neuroleptic Malignant Syndrome. Int Med J. 2019;26(4):351-352.

  98. Nakamura M, Nagamine T. Recurrence of eosinophilic pneumonia after clozapine treatment. Asian J Psychiatr. 2019;44(1):4-5.

  99. Nakamura M, Sato Y, Nagamine T. Lamotrigine-induced Severe Hyponatremia developed Takotsubo cardiomyopathy. Innov Clin Neurosci. 2019;16(7-8):32-34.

  100. Nagamine T. Letter to the editor on ‘ PCR as a Diagnostic Tool for Extra-Pulmonary Tuberculosis’. J Clin Diagn Res.2019;13(10):OL01.

  101. Nagamine T. Acute psychosis secondary to atypical Bickerstaff brainstem encephalitis. Asian J Psychiatr.2019;46:49-50.

  102. Takayama A, Nagamine T, Kotani K. Aging is independently associated with the increasing normal respiratory rate among elderly population in a clinical setting: A cross-sectional study. Geriatr Gerontol Int. 2019;19(11):1179-1183.

  103. Nagamine T. Correspondence, ‘Influenza as a Cause of SIADH Related Hyponatremia’. J Clin Diagn Res.2019;13(11):OL02.

  104. Nakamura M, Nagamine T. Brexpiprazole as a New Serotonin–Dopamine Receptor Modulator: Considering the Clinical Relevance for Metabolic Parameters and Prolactin Levels. Innov Clin Neurosci. 2019;16(9–10):30–32.

  105. Nagamine T, Takayama A, Matsumoto Y. Characteristics of the Cavity of Mycobacterial Diseases by Chest Computed Tomography. Int Med J. 2019;26(6):539.

  106. Nagamine T, Takayama A, Matsumoto Y. Cardiac Tamponade due to Chronic Idiopathic Pericardial Effusion in an Emergency Medical Setting. Int Med J. 2019;26(6):540.

  107. Nagamine T. Primary prevention of Clostridioides difficile infection with combination probiotics. J Hosp Infect. 2020;104:80-81.

  108. NagamineT. Correspondence, ‘Curious case of myocardial infarction caused by lung abscess’; From the Viewpoint of Type 2 myocardial infarction by Chest Trauma. J Clin Diagn Res.2019;13(12):OL01-02.

  109. Suga T, Watanabe T, Trang T.H Tu, Kawasaki K, Sugawara S, Mikuzuki L, Hong C, Shinohara Y, Miura K, Takenoshita M, Yoshikawa T, Nagamine T, Toyofuku A. The Therapeutic Dose of Amitriptyline for Older Patients with Burning Mouth Syndrome. Neuropsychiatr. Dis. Treat.2019;15:3599-3607.

  110. Nagamine T. Letter Regarding the Article, ‘Hyponatremia in Patients Admitted with Stroke’; From the Viewpoint of Similarity to Hyponatremia Associated with Traumatic Brain Injury. J Clin Diagn Res.2020;14(2):OL01-OL02.

  111. NagamineT. Correspondence-‘Role of Diffusion Weighted Imaging in Differentiating Benign from Pathological Vertebral Collapse using ADC Values’; Is It Possible to Discriminate Multiple Myeloma with Magnetic Resonance Imaging? J Clin Diagn Res. 2020 Mar, Vol-14(3): TL01-TL02.

  112. Takayama A, Nagamine T, Kotani K. Contrasting characters of quick methods to measure respiratory rate in a clinical setting. Clin Respir J. 2020 Mar 18. doi: 10.1111/crj.13187. [Epub ahead of print]

  113. Nagamine T. Duloxetine, a serotonin and norepinephrine reuptake inhibitor, may be a double-edged sword for patients with advanced Parkinson's disease. Asian J Psychiatr. Available online 28 March 2020. doi.org/10.1016/j.ajp.2020.102031.

  114. Nagamine T, Takayama A, Matsumoto Y. Low-Dose and Short-Term Corticosteroid Therapy for Aspiration-Induced Lung Injury in an Elderly Patient with Alzheimer's Disease. Int Med J.2020;27(2):118-119.

  115. Nakamura M, Nagamine T. Eosinophilic pneumonia during treatment with clozapine: reports from a retrospective case series. Int Clin Psychopharmacol.2020 Apr 8. doi: 10.1097/YIC.0000000000000311.

  116. Takayama A, Nagamine T. Reply to the comments on “Aging is independently associated with an increasing normal respiratory rate among older adults without pulmonary disease and chronic heart failure”. Geriatr. Gerontol. Int. 2020;20:505–506.

  117. Nagamine T. Correspondence: Association of Serum Uric Acid Level with the Severity of Brain Injury and Patient’s Outcome in Severe Traumatic Brain Injury. J Clin Diagn Res.2020 Jun, Vol-14(6): OL01.

  118. Nagamine T. SARS-CoV-2 and Receptor Protein. Int Med J. 2020;27(3):247.

  119. Nagamine T. Lithium intoxication in the elderly: A possible interaction between azilsartan, fluvoxamine, and lithium. Innov Clin Neurosci.2020;17(4-6):45-46.

  120. Nagamine T. Gastric Dilatation due to Japanese Noodle Udon in an Elderly Patient with Depression. Int Med J. 2020;27(4):386-387.

  121. Nagamine T. Cognitive decline due to the cerebral cavernous malformations. Aust N Z J Psychiatry.2020:54; DOI: 10.1177/0004867420951613

  122. Nagamine T, Nakamura M. The effect of probiotics on bowel movement and metabolic parameters in schizophrenia patients; A retrospective chart review. Biosci Microbiota Food Health. 2020;39(4):197-198.

  123. Nagamine T. ROLE OF NOREPINEPHRINE IN SCHIZOPHRENIA: AN OLD THEORY APPLIED TO A NEW CASE IN EMERGENCY MEDICINE. Innov Clin Neurosci. 2020;17(7–9):8–9.

  124. Nagamine T. Severe hypoglycemia in an elderly patient with Alzheimer’s disease and with sepsis; The role of neurotransmitters on glucose regulation. Geriatr Gerontol Int. 2021;21(1):116-117.

  125. Ninagawa S, Tada S, Okumura M, Inoguchi K, Kinoshita M, Kanemura S, Imami K, Umezawa H, Ishikawa T, Okada T, Robert B. Mackin, Torii S, Ishihama Y, Inaba K,  Anazawa T, Nagamine T and Mori K. The antipsychotic olanzapine-induced misfolding of proinsulin in the endoplasmic reticulum accounts for atypical development of diabetes. Elife.2020 Nov 17;9:e60970. DOI: 10.7554/eLife.60970

  126. Nagamine T. Atypical diabetes mellitus caused by olanzapine. Aust N Z J Psychiatry. 2021 Jan 9:4867420984232.

  127. Suga T, Tu TTH, Nagamine T, Toyofuku A. Careful use of clonazepam and alpha lipoid acid in burning mouth syndrome treatment. Oral Dis. 2021 Jan 13.

  128. Nakamura M, NagamineT. Prevalence and predictors of laxative use in clozapine-related constipation: An observational study. Int Clin Psychopharmacol.2021;36

  129. Nagamine T. Long-term preoperative use of zolpidem is associated with postoperative delirium in elderly patients undergoing hip surgery. Psychogeriatrics. 2021 Apr 13.

  130. Nagamine T. Minor head injury might cause cognitive impairment due to severe hyponatremia. Innov Clin Neurosci.2021;18(1-3):47-48.

  131. Nagamine T. Beware of traumatic anosmia in COVID-19 pandemic. CJEM.2021: 10.1007/s43678-021-00135-6

  132. Nagamine T. Perspectives on Emergency Medicine in Psychiatry. Int Med J.2021;28(3):278-279.

  133. Nagamine T. Biliary pseudolithiasis in an elderly patient treated with lascufloxacin. Geriatr. Gerontol. Int. 2021;1–2. https://doi.org/10.1111/ggi.14212.

  134. Nagamine T. Peer Review Report For: The effects of the glycaemic control on the severity of the delirium in the advanced phase of Alzheimer’s disease. F1000Research 2020, 9:1470 https://f1000research.com/articles/9-1470/v1#referee-response-89381

  135. Nagamine T. Effect of Sodium Valproate on Cellular Organelles. Int Med J.2021;28(4):370.

  136. Nagamine T. Beware of Biphasic Anaphylaxis. J Emerg Med. 2021;61(2):207-208.

  137. Nagamine, T. Foreign accent syndrome associated with left insula infarction after COVID-19 pneumonia. CJEM. 2021. https://doi.org/10.1007/s43678-021-00196-7.

  138. Nagamine T. The Potential of Probiotics in the Treatment of Schizophrenia. Clin Neuropsychopharmacol Ther. 2021;12:18-22.

  139. Nagamine T. Beware of Neuroleptic Malignant Syndrome in COVID-19 Pandemic. Innov Clin Neurosci.2021;18(7-9):9-10.

  140. Nakamura M, Nagamine T. Metabolic Effects of Clozapine Administration Based on Sex Differences and the Relationships Between Dosage and Prolactin Levels: An Observational Study. Clin Neuropharmacol. 2021 Sep 24. doi: 10.1097/WNF.0000000000000482.

  141. Nagamine, T. BRASH syndrome associated with angiotensin receptor blocker and SGLT2 inhibitor. CJ EM.2021. https://doi.org/10.1007/s43678-021-00213-9.

  142. Nagamine T. Brain-Gut-Microbiota Axis in Schizophrenia and Parkinson's Disease. Int Med J. 2021:28(6):590-591.

  143. Nagamine T. Duloxetine-induced Hyponatremia can Occur in Not Only Syndrome of Inappropriate Secretion of Antidiuretic Hormone but Also Cerebral Salt Wasting Syndrome. Intern Med. 2021 Dec 11. doi: 10.2169/internalmedicine.8666-21.

  144. Nagamine T. Neuroleptic malignant syndrome associated with COVID-19 vaccination. CJEM. 2021 Dec 17. doi: 10.1007/s43678-021-00254-0.

  145. Motoko Watanabe, Chihiro Takao, Zhenyan Liu, Gayatri Nayanar, Takayuki Suga, Chaoli Hong, Trang Thi Huyen Tu, Tatsuya Yoshikawa, Miho Takenoshita, Haruhiko Motomura, Takahiko Nagamine and Akira Toyofuku. The Effectiveness and Adverse Events of Amitriptyline and Aripiprazole in Very Elderly Patients With BMS. Front Pain Res., 04 March 2022 | https://doi.org/10.3389/fpain.2022.809207

  146. Nagamine T. Beware of Serotonin Overload in Pharmacotherapy for Elderly Patients with Burning Mouth Syndrome. Psychogeriatrics. 2022.doi:10.1111/psyg.12823

  147. Nagamine T. Beware of serotonin syndrome during the COVID-19 pandemic. Aust N Z J Psychiatry. 2022 Mar 31:48674221090175.

  148. Nagamine T. Beware of Extrapulmonary Tuberculosis. Int Med J. 2022:29(2):82-83.

  149. Nagamine T. How to facilitate respiratory rate measurement in the emergency room. Jpn J Nurs Sci. 2022;e12493.

  150. Takayama A, Takeshima T, Nagamine T. Factors associated with the frequency of respiratory rate measurement by hospital nurses: a multicentre cross-sectional study. Br J Nurs. 2022 May 12;31(9):495-501.

  151. Nagamine T. Transient global amnesia with transient anosmia: A curious case suggestive of middle cerebral artery occlusion. J Integr Neurosci. 2022; 21(4): 103.

  152. Nagamine T. Two-hit theory by estrogen in burning mouth syndrome. J Dent Sci. 2022; https://doi.org/10.1016/j.jds.2022.06.009

  153. Suga T, Nagamine T, Trang T.H Tu, Moriyama K, Toyofuku A. Orthognathic surgery for patients with neurodevelopmental disorders requires careful decision-making by a multidisciplinary team. Innov Clin Neurosci. 2022;19(4–6):9–10.

  154. Nakamura M, Nagamine T. Impact of lurasidone on metabolic parameters and prolactin levels based on differences of psychiatric diagnosis, dosage, and introducing methods: An observational study. Innov Clin Neurosci. 2022;19(4–6):70-77.

  155. Nagamine T. Predictive Resting Metabolic Rate in Patients with Type 2 Diabetes Mellitus. Int Med J.2022;29(4):222-223.

  156. Sumi S, Nagamine T, Sumi K, Aujima R, Oka K, Toyofuku A. Open Bite as an Extrapyramidal Side Effect with Aripiprazole, a Dopamine Partial Agonist. Front Psychiatry. 2022.06 September. DOI 10.3389/fpsyt.2022.976387

  157. Nagamine T. Role of dopamine in cortico-basal ganglia loop in psychosis. Atlas of Science. October 18, 2022. https://atlasofscience.org/role-of-dopamine-in-cortico-basal-ganglia-loop-in-psychosis/

  158. Nagamine T. Neuroleptic Malignant Syndrome or Serotonin Syndrome? Psychiatr Danub.2022;34(3):526-527.

  159. Nagamine T. Optimal Dosage of Antidepressants in the Treatment of Burning Mouth Syndrome. Psychiatr Danub.2022;34(3):527-528.

  160. Sumi S, Nagamine T, Sumi K, Aijima R, Oka K, Toyofuku A. Modulation of intracellular dopamine signaling by aripiprazole may cause malocclusion as an extrapyramidal symptom. Atlas of Science. October 24, 2022. https://atlasofscience.org/modulation-of-intracellular-dopamine-signaling-by-aripiprazole-may-cause-malocclusion-as-an-extrapyramidal-symptom/

  161. Nakamura M, Nagamine T. Clozapine-induced fever and plasma cytokine changes in a patient with schizophrenia. Clin Neuropharmacol.2022 Nov 1. online ahead of print.

  162. Nagamine T. Research Methods for Creating the Discipline of Community Medicine. Monthly Community Medicine.2022;36(11):1024-1026.

  163. Nagamine T. Olanzapine-induced endoplasmic reticulum stress induces atypical diabetes and diabetic ketoacidosis. Innov Clin Neurosci.2022;19(10-12):8-9.

  164. Takayama A, Yoshioka T, Nagamine T. Impact of beta blockers on resting respiratory rate in older adults: A cross-sectional study. Pulm Pharmacol Ther. 2023 Jan 2:102186. doi: 10.1016/j.pupt.2022.102186.

  165. Asami M, Kimura Y, Takenoshita M, Tominaga R, Maeda C, Takao C, Watanabe M, Trang T Huyen Tu, Nagamine T, Toyofuku A. Dental conditions in patients with medically unexplained oral symptoms. J Dent Sci. 2023, https://doi.org/10.1016/j.jds.2023.01.005

  166. Nagamine T, Nakamura M. Mild Decrease in Blood Glucose Levels May Predict Efficacy of Antipsychotic Lurasidone. Clin Psychopharmacol Neurosci. 2023 Feb 28;21(1):207-209.

  167. Nagamine T. Omicron variant infections and multiple strokes in older adults. Geriatr. Gerontol. Int.2023.epub ahead. https://doi.org/10.1111/ggi.14549.

  168. Gayatri Krishnakumar Nayanar, Trang Thi Huyen Tu, Nagamine T, Toyofuku A. The assessment of long-term prognosis of burning mouth syndrome following treatment necessitates a reappraisal. Int J Oral Maxillofac Surg. 2023; Feb8. doi.org/10.1016/j.ijom.2023.01.011

  169. Nagamine T. Serotonin Paradox in Burning Mouth Syndrome. J Clin Psychopharmacol. 2023 Feb 27. doi: 10.1097/JCP.0000000000001661.

  170. Nagamine T. Beware of bihemispheric stroke after Omicron variant infection in the elderly. Brain Circ.2023;9(1):52-54.

  171. Nagamine T. Somatization and Medicalization in Patients with Unexplained Orofacial Pain. Alpha Psychiatry.2023;24(2):75-76.

  172. Watanabe M, Trang Thi Huyen Thi, Takao C, Maeda C, Gayatri Krishnakumar Nayanar, Tominaga R, Kimura Y, Takenoshita M, Yoshikawa T, Sumi K, Sumi S, Motomura H, NagamineT, Toyofuku A. Case series of drug-induced open bite; extrapyramidal symptoms related to psychotropic medications. Frontiers in Psychiatry. 2023; March28: DOI 10.3389/fpsyt.2023.1137917

  173. Ido Y, Yano M, Tarutani S, Nagamine T. High Prevotella-to-Bacteroides ratio Predicts Antidepressant Effect of 4G-beta-D-Galactosylsucrose. Int Med J.2023;30(2):120-121.

  174. Nagamine T. Preventing dehydration can help ensure safe use of psychotropic medications in the elderly. Psychogeriatrics.2023. doi:10.1111/psyg.12968

  175. Nakamura M, Nagamine T. Omicron variant infection may not exert an influence on serum levels of clozapine. J Clin Psychopharmacol. 2023;43(5). DOI: 10.1097/JCP.0000000000001733

  176. Nagamine T. Differences between Japan and Canada in Emergency Transport Systems for Relatively Young Stroke Patients. Int Med J. 2023;30(3):126-127.

  177. Ido Y, Miura M, Nagamine T. Effects of lactosucrose on allergic rhinitis from the viewpoint of changes in intestinal microbiota. Int Med J.2023;30(3):159-161.

  178. Nagamine T. Open bite malocclusion following aripiprazole treatment in children and adolescents. Innov Clin Neurosci.2023;20(4-6):9-10.

  179. Maeda C, Watanebe M, Trang TH Tu, Takao C, Gayatri K Nayanar, Tominaga R, Kimura Y, Nagamine T, Toyohuku A. Psychiatric comorbidities in chronic orofacial pain during Covid-19 pandemic. J Psychosom Res. 2023;172:https://doi.org/10.1016/j.jpsychores.2023.111420

  180. Nagamine T. Pain threshold paradox in schizophrenia: a narrative review based on the latest neuroscience. Psychiatr Danub.2023;35(2):174-179.

  181. Nagamine T. Restlessness with manic episodes induced by right-sided multiple strokes after COVID-19 infection: A case report. Brain Circ.2023;9(2):112-115.

  182. Maeda C, Nagamine T, Takao C, Tominaga R, Kimura Y, Watanabe M, Toyofuku A. Are the Effects of Amitriptyline and Aripiprazole on Pain Catastrophizing in Patients with Burning Mouth Syndrome Associated with Changes in QTc and Prolactin Levels? Int Med J.2023;30(4):178-182.

  183. Nagamine T. Venous Neurovascular Compression and Chronic Orofacial Pain. World Neurosurg.2023;176:242.

  184. Nagamine T. Antiviral therapy for COVID-19 may not reduce stroke complications. Neur Ind. 2023:71(4):796-797.

  185. Nagamine T. Sepsis associated with sodium glucose co-transporter 2 inhibitor in an elderly patient with chronic kidney disease. Geriatr. Gerontol. Int. 2023;September 5.  https://doi.org/10.1111/ggi.14659

  186. Nagamine T. Photo Quiz: New onset of extreme bradycardia. Am Fam Physician. 2023;108(4):417-419.

  187. Nagamine T. Labial Adhesion with Repeated Femur Fractures in an Elderly Woman. Int Med J. 2023; 30(6).

  188. Murata T, Uno K, Ito M, Nagamine T. Leukopenia associated with lamotrigine initiation after COVID-19 vaccine booster: A case report and literature review. Int J Clin Pharmacol Ther. 2023 Nov 9. doi: 10.5414/CP204452.

  189. Nagamine T. Beware of attention-deficit/hyperactivity disorder (ADHD) in older adults. Psychogeriatrics. 2023 Nov 15. doi: 10.1111/psyg.13048.

  190. Nagamine T. Uric acid levels with tolvaptan treatment for syndrome of inappropriate antidiuretic hormone secretion. Endocrine. 2023 Nov 20. doi: 10.1007/s12020-023-03612-3.

  191. Nagamine T. Poststroke Mania during the COVID-19 Pandemic. J Nerv Ment Dis.2023;211:979-980.

  192. Nagamine T. Burning mouth syndrome needs to consider the gut-brain axis from three types of pain: nociceptive, neuropathic, and nociplastic pain.  J Gastrointestin Liver Dis.2023;32(4)558-559.

  193. Takao C, Watanabe M, Gayatri Nayanar, Trang Thi Huyen, Maeda C, Tominaga R, Kimura Y, Umezaki Y, Takenoshita M, Motomura H, Nagamine T, Toyofuku A. Clinical Features and Variations of Pain Expressions in 834 Burning Mouth Syndrome Patients With or Without Psychiatric Comorbidities. Cureus 2023;15(12): e51139. doi:10.7759/cureus.51139 (December 26, 2023)

  194. Nagamine T. Spontaneous pneumomediastinum in a middle-aged female patient with schizophrenia: A Case Report. Cureus.2024;16(1): e51887. DOI 10.7759/cureus.51887

  195. Nagamine T. Effect of magnesium oxide with probiotics on bowel movements in elderly orthopedic patients with chronic constipation: a retrograde chart review. Biosci Microbiota Food Health. 2024;43(1):1-3.

  196. Murata T, Uno K, Nagamine T. Guanfacine Used With Antipsychotics May Cause Bradycardia to Become Apparent After Discontinuation of Antipsychotics. Am J Ther. 2024 Jan 18. doi: 10.1097/MJT.0000000000001654.

  197. Nagamine T, Watanabe T, Toyofuku A. QTc Shortening on Electrocardiogram with Amitriptyline May Indicate no Effect on Pain Relief in Burning Mouth Syndrome. Clin Neuropharmacol.2024;January29,10.1097/WNF.0000000000000583. DOI: 10.1097/WNF.0000000000000583

  198. Nagamine T, Watanabe T. QTc interval and sympathetic tone in burning mouth syndrome. Brain & Heart. 2024.https://doi.org/10.36922/bh.2016

  199. Watanabe M, Tu TTH, Nagamine T, Toyofuku A. Goal Attainment Scaling in Patients With Burning Mouth Syndrome: A Real-world Clinical Study Protocol. Cureus. 2024;16(2): e54392. DOI 10.7759/cureus.54392.

  200. Nagamine T, Watanabe T. The catastrophic perception of pain in burning mouth syndrome may be associated with sympathetic tone as indicated by the QTc interval. Innv Clin Neurosci.2024;21(1-3):8-9.

  201. Watanabe M, Takao C, Maeda C, Tominaga R, Kimura Y, Nayanar G, Trang Thi Huyen Tu, Nagamine T, Toyofuku A. The effective perospirone augmentation with clonazepam for treatment resistant burning mouth syndrome: A case report. Neuropsychopharmacol Rep. 2024;00:1–4. https://doi.org/10.1002/npr2.12425

  202. Nakamura M, Nagamine T. Acute Psychosis Secondary to Isolated Adrenocorticotropic Hormone Deficiency Treated with Imatinib. Int Med J.2024;31(2):46-49.

  203. Nagamine T. What is an Efficient Emergency Medical Care System in a Medium-Sized City? Int Med J.2024;31(2):53-54.

  204. Nagamine T. Amitriptyline at low dose for burning mouth syndrome. Oral Dis. 2024 Apr 15. doi: 10.1111/odi.14966.

Journal Publications

PUBLICATIONS

bottom of page